Fagron NV (FAGR.BR) — the peer cohort
As of 2026-10-12 — scores re-bake nightly. Cohort = shared Closelooknet index membership first, then sector. Diary readings, not advice.
Fagron NV ranks 12 of 14 in its cohort on the Closelooknet composite (52/100) — the cohort is led by Halozyme Therapeutics Inc at 74/100.
| Name | Composite | Momentum | Quality | Valuation | Signal | Off 52w high |
|---|---|---|---|---|---|---|
| FAGR.BR Fagron NV | 52 | 42 | 54 | 59 | info | 11.5% |
| ROVI.MC Laboratorios Farmaceuticos ROVI | 61 | 28 | 76 | 50 | warn | 31.3% |
| LNTH Lantheus Holdings Inc | 60 | 70 | 73 | 54 | info | 10.5% |
| KNSA Kiniksa Pharmaceuticals Ltd | 56 | 94 | 57 | 19 | ok | 4.5% |
| BHC.TO Bausch Health Companies Inc | 55 | 66 | 70 | 82 | info | 22% |
| GALDY GALDERMA GROUP AG | 55 | 50 | 57 | 26 | info | 13.2% |
| ALKS Alkermes Plc | 51 | 50 | 51 | 23 | info | 27.7% |
| ARGX.BR Argen-X | 63 | 56 | 75 | 29 | info | 20.7% |
| UCB.BR UCB SA | 60 | 17 | 69 | 57 | warn | 29.3% |
| TUB.BR Tubize-Fin | 25 | 15 | 18 | 25 | warn | 30.6% |
| HALO Halozyme Therapeutics Inc | 74 | 94 | 94 | 48 | ok | 4.9% |
| DXCM DexCom Inc | 66 | 85 | 80 | 35 | bull | 9.2% |
| LLY Eli Lilly and Company | 64 | 73 | 91 | 27 | bull | 8.8% |
| ONC BeiGene, Ltd. | 63 | 76 | 62 | 30 | info | 9% |
Scores are relative readings across the Closelooknet coverage universe — methodology in the company-scoring explainer. Signal lights come from the nightly signal board.
FAQ · from the current data · as of 2026-10-12
Quick answers
Who are Fagron NV's peers in the Closelooknet universe?
The cohort is drawn from shared Closelooknet index membership first, then sector: Laboratorios Farmaceuticos ROVI (ROVI.MC), Lantheus Holdings Inc (LNTH), Kiniksa Pharmaceuticals Ltd (KNSA), Bausch Health Companies Inc (BHC.TO), GALDERMA GROUP AG (GALDY), Alkermes Plc (ALKS), Argen-X (ARGX.BR), UCB SA (UCB.BR) and others.
How does FAGR.BR score against its peers?
Fagron NV's composite reads 52/100, ranking 12 of 14 in its cohort as of 2026-10-12; the cohort's highest composite is Halozyme Therapeutics Inc at 74/100. Closelooknet scores are research diary readings, not ratings or advice.
Related in the Closelooknet universe
then Drug Manufacturers - Specialty & Generic, then Healthcare. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.
- ROVI.MC Laboratorios Farmaceuticos ROVIindustry
- LNTH Lantheus Holdings Incindustry
- KNSA Kiniksa Pharmaceuticals Ltdindustry
- BHC.TO Bausch Health Companies Incindustry
- GALDY GALDERMA GROUP AGindustry
- ALKS Alkermes Plcindustry
- PRGO Perrigo Company PLCindustry
- HCM.L HUTCHMED China Ltdindustry
- AMRX Amneal Pharmaceuticals, Inc. Class A Common Stockindustry
- UTHR United Therapeutics Corporationindustry
- VTRS Viatris Incindustry
- ZTS Zoetis Incindustry
- DMP.DE Dermapharm Holding SEindustry
- ELAN Elanco Animal Healthindustry
- ALM.MC Almirall S.A.industry
- NBIX Neurocrine Biosciences Incindustry
- APTX.TO Apotex Health Corpindustry
- ARGX.BR Argen-Xsector
- UCB.BR UCB SAsector
- TUB.BR Tubize-Finsector